Trial intelligence / Profile preview

Intra-articular levobupivacaine with tenoxicam, nalbuphine, or magnesium sulphate for pain after knee arthroscopy

PACTR201704002155170Not yet recruiting

Sponsor
Hatem Elmoutaz
Start
Apr 2017
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of levobupivacaine, tenoxicam, nalbuphine and magnesium sulfate in postoperative pain (3 arms), sponsored by Hatem Elmoutaz. Primary endpoint: Numeric Rating Scale pain score at passive motion. Planned start Apr 2017; status: not yet recruiting.

02

Drugs

levobupivacainetenoxicamnalbuphinemagnesium sulfate
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR201704002155170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201704002155170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call